Label: GLIPIZIDE tablet, extended release
-
NDC Code(s):
70771-1098-0,
70771-1098-1,
70771-1098-2,
70771-1098-3, view more70771-1098-4, 70771-1098-5, 70771-1098-6, 70771-1098-9, 70771-1099-0, 70771-1099-1, 70771-1099-2, 70771-1099-3, 70771-1099-4, 70771-1099-5, 70771-1099-6, 70771-1099-9, 70771-1100-0, 70771-1100-1, 70771-1100-2, 70771-1100-3, 70771-1100-4, 70771-1100-5, 70771-1100-6, 70771-1100-9
- Packager: Zydus Lifesciences Limited
- Category: HUMAN PRESCRIPTION DRUG LABEL
Drug Label Information
Updated October 13, 2022
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
- PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
GLIPIZIDE
glipizide tablet, extended releaseProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:70771-1098 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength GLIPIZIDE (UNII: X7WDT95N5C) (GLIPIZIDE - UNII:X7WDT95N5C) GLIPIZIDE 2.5 mg Inactive Ingredients Ingredient Name Strength ACETYLTRIBUTYL CITRATE (UNII: 0ZBX0N59RZ) ALUMINUM OXIDE (UNII: LMI26O6933) AMMONIA (UNII: 5138Q19F1X) BUTYL ALCOHOL (UNII: 8PJ61P6TS3) FD&C YELLOW NO. 5 (UNII: I753WB2F1M) FERROSOFERRIC OXIDE (UNII: XM0M87F357) HYDROXYETHYL CELLULOSE (2000 CPS AT 1%) (UNII: S38J6RZN16) HYDROXYPROPYL CELLULOSE, UNSPECIFIED (UNII: 9XZ8H6N6OH) HYPROMELLOSES (UNII: 3NXW29V3WO) ISOPROPYL ALCOHOL (UNII: ND2M416302) LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) MAGNESIUM STEARATE (UNII: 70097M6I30) METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1) (UNII: 74G4R6TH13) POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) PROPYLENE GLYCOL (UNII: 6DC9Q167V3) SHELLAC (UNII: 46N107B71O) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) Product Characteristics Color YELLOW (Yellow) Score no score Shape ROUND (Round) Size 6mm Flavor Imprint Code 2 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:70771-1098-3 30 in 1 BOTTLE; Type 0: Not a Combination Product 07/25/2018 2 NDC:70771-1098-6 60 in 1 BOTTLE; Type 0: Not a Combination Product 07/25/2018 3 NDC:70771-1098-9 90 in 1 BOTTLE; Type 0: Not a Combination Product 07/25/2018 4 NDC:70771-1098-1 100 in 1 BOTTLE; Type 0: Not a Combination Product 07/25/2018 5 NDC:70771-1098-5 500 in 1 BOTTLE; Type 0: Not a Combination Product 07/25/2018 6 NDC:70771-1098-0 1000 in 1 BOTTLE; Type 0: Not a Combination Product 07/25/2018 7 NDC:70771-1098-4 10 in 1 CARTON 07/25/2018 7 NDC:70771-1098-2 10 in 1 BLISTER PACK; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA203499 07/25/2018 GLIPIZIDE
glipizide tablet, extended releaseProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:70771-1099 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength GLIPIZIDE (UNII: X7WDT95N5C) (GLIPIZIDE - UNII:X7WDT95N5C) GLIPIZIDE 5 mg Inactive Ingredients Ingredient Name Strength ACETYLTRIBUTYL CITRATE (UNII: 0ZBX0N59RZ) AMMONIA (UNII: 5138Q19F1X) BUTYL ALCOHOL (UNII: 8PJ61P6TS3) FD&C YELLOW NO. 6 (UNII: H77VEI93A8) FERROSOFERRIC OXIDE (UNII: XM0M87F357) HYDROXYETHYL CELLULOSE (2000 CPS AT 1%) (UNII: S38J6RZN16) HYDROXYPROPYL CELLULOSE, UNSPECIFIED (UNII: 9XZ8H6N6OH) HYPROMELLOSES (UNII: 3NXW29V3WO) ISOPROPYL ALCOHOL (UNII: ND2M416302) LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) MAGNESIUM STEARATE (UNII: 70097M6I30) METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1) (UNII: 74G4R6TH13) POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) PROPYLENE GLYCOL (UNII: 6DC9Q167V3) SHELLAC (UNII: 46N107B71O) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) Product Characteristics Color ORANGE (Orange) Score no score Shape ROUND (Round) Size 6mm Flavor Imprint Code 3 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:70771-1099-3 30 in 1 BOTTLE; Type 0: Not a Combination Product 07/25/2018 2 NDC:70771-1099-6 60 in 1 BOTTLE; Type 0: Not a Combination Product 07/25/2018 3 NDC:70771-1099-9 90 in 1 BOTTLE; Type 0: Not a Combination Product 07/25/2018 4 NDC:70771-1099-1 100 in 1 BOTTLE; Type 0: Not a Combination Product 07/25/2018 5 NDC:70771-1099-5 500 in 1 BOTTLE; Type 0: Not a Combination Product 07/25/2018 6 NDC:70771-1099-0 1000 in 1 BOTTLE; Type 0: Not a Combination Product 07/25/2018 7 NDC:70771-1099-4 10 in 1 CARTON 07/25/2018 7 NDC:70771-1099-2 10 in 1 BLISTER PACK; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA203499 07/25/2018 GLIPIZIDE
glipizide tablet, extended releaseProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:70771-1100 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength GLIPIZIDE (UNII: X7WDT95N5C) (GLIPIZIDE - UNII:X7WDT95N5C) GLIPIZIDE 10 mg Inactive Ingredients Ingredient Name Strength ACETYLTRIBUTYL CITRATE (UNII: 0ZBX0N59RZ) AMMONIA (UNII: 5138Q19F1X) BUTYL ALCOHOL (UNII: 8PJ61P6TS3) FERROSOFERRIC OXIDE (UNII: XM0M87F357) HYDROXYETHYL CELLULOSE (2000 CPS AT 1%) (UNII: S38J6RZN16) HYDROXYPROPYL CELLULOSE, UNSPECIFIED (UNII: 9XZ8H6N6OH) HYPROMELLOSES (UNII: 3NXW29V3WO) ISOPROPYL ALCOHOL (UNII: ND2M416302) LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) MAGNESIUM STEARATE (UNII: 70097M6I30) METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1) (UNII: 74G4R6TH13) POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) PROPYLENE GLYCOL (UNII: 6DC9Q167V3) SHELLAC (UNII: 46N107B71O) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) Product Characteristics Color WHITE (White) Score no score Shape ROUND (Round) Size 6mm Flavor Imprint Code 4 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:70771-1100-3 30 in 1 BOTTLE; Type 0: Not a Combination Product 07/25/2018 2 NDC:70771-1100-6 60 in 1 BOTTLE; Type 0: Not a Combination Product 07/25/2018 3 NDC:70771-1100-9 90 in 1 BOTTLE; Type 0: Not a Combination Product 07/25/2018 4 NDC:70771-1100-1 100 in 1 BOTTLE; Type 0: Not a Combination Product 07/25/2018 5 NDC:70771-1100-5 500 in 1 BOTTLE; Type 0: Not a Combination Product 07/25/2018 6 NDC:70771-1100-0 1000 in 1 BOTTLE; Type 0: Not a Combination Product 07/25/2018 7 NDC:70771-1100-4 10 in 1 CARTON 07/25/2018 7 NDC:70771-1100-2 10 in 1 BLISTER PACK; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA203499 07/25/2018 Labeler - Zydus Lifesciences Limited (918596198) Registrant - Zydus Lifesciences Limited (918596198) Establishment Name Address ID/FEI Business Operations Zydus Lifesciences Limited 918596198 ANALYSIS(70771-1098, 70771-1099, 70771-1100) , MANUFACTURE(70771-1098, 70771-1099, 70771-1100)